trastuzumab

Italy

Drugs containing this active substance

  • DAZUBLYS

    It is prescribed for the treatment of breast cancer (early stage or metastatic) and gastric cancer, provided that high levels of a protein called HER2 are present.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

    Manufacturer: CURATEQ BIOLOGICS S.R.O

  • HERCEPTIN

    It is prescribed for the treatment of breast cancer (early stage or metastatic) and metastatic gastric cancer, but only in patients who have high levels of the HER2 protein.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

    Manufacturer: ROCHE REGISTRATION GMBH

  • HERZUMA

    It is prescribed for the treatment of breast cancer (early stage or metastatic) and metastatic gastric cancer, but only in cases where the tumor cells show high levels of a protein called HER2.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

    Manufacturer: CELLTRION HEALTHCARE HUNGARY KFT

  • KANJINTI

    It is prescribed for the treatment of breast cancer (early stage or metastatic) and gastric cancer, but only in cases where the tumor cells show high levels of a protein called HER2.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

    Manufacturer: AMGEN EUROPE B.V.

  • OGIVRI

    This medicine is prescribed for the treatment of breast cancer (early stage or metastatic) and metastatic gastric cancer, provided that high levels of a protein called HER2 are present.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

    Manufacturer: BIOSIMILAR COLLABORATIONS IRELAND LIMITED

  • ONTRUZANT

    Ontruzant is prescribed for the treatment of breast cancer (early stage or metastatic) and metastatic gastric cancer, provided that the tumor cells show high levels of a protein called HER2.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

    Manufacturer: SAMSUNG BIOEPIS NL B.V.

  • PHESGO

    It is an anticancer medicinal product used for the treatment of adult patients with 'HER2-positive' breast cancer. It can be used both when the tumor has spread to other parts of the body (metastasized) or has recurred in an inoperable manner, and before or after surgery.

    Form: solution for injection

    Active substance Dosage
    pertuzumab -
    trastuzumab -

    ATC: L01FY01

    Manufacturer: ROCHE REGISTRATION GMBH

  • TRAZIMERA

    It is prescribed for the treatment of breast cancer (early stage or metastatic) and metastatic gastric cancer, but only in cases where the tumor cells show high levels of a protein called HER2.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

    Manufacturer: PFIZER EUROPE MA EEIG

  • TUZNUE

    Tuznue is prescribed for the treatment of breast cancer (both early-stage and metastatic) and gastric cancer, but only in cases where the tumor cells show high levels of a specific protein called HER2.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

    Manufacturer: PRESTIGE BIOPHARMA BELGIUM BVBA

  • ZERCEPAC

    This medicine is prescribed for the treatment of breast cancer (both early stage and metastatic) and gastric cancer, but only in cases where the tumor cells show high levels of a protein called HER2.

    Form: powder for concentrate for infusion solution

    Active substance Dosage
    trastuzumab -

    ATC: L01FD01

    Manufacturer: ACCORD HEALTHCARE, S.L.U.